Want to see HK:1526 full AI Analyst Report?
1526 Stock Chart & Stats
HK$1.07
HK$0.00(0.00%)
At close: 4:00 PM EDT
HK$1.07
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$0.56 - HK$1.24
Previous CloseN/A
Volume83.00K
Average Volume (3M)125.43K
Market Cap
HK$1.64B
Enterprise ValueHK$1.99B
Total Cash (Recent Filing)HK$1.18B
Total Debt (Recent Filing)HK$2.01B
Price to Earnings (P/E)5.0
Beta0.29
Next Earnings
Sep 01, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.94%
Share Statistics
EPS (TTM)0.18
Shares Outstanding1,590,324,000
10 Day Avg. Volume143,000
30 Day Avg. Volume125,433
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)0.97
Price to Sales (P/S)0.57
P/FCF Ratio2.85
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
High Operating And Net MarginsSustained mid-to-high margins indicate structural profitability from service-based operations and operational scale. With gross and EBIT margins near the mid-teens to twenties and net margin ~11%, the business can generate durable earnings and absorb cost pressures while funding reinvestment over multiple quarters.
Strong Cash GenerationRobust operating and free cash flow provide a durable internal funding source for capex, dividends, and debt reduction. The sizable FCF base and an upward trend (notably in 2025) reduce reliance on external financing and support steady investment in facilities and services over the coming quarters.
Improving Leverage & Strong ROEA declining D/E ratio alongside high-teens ROE signals improving capital structure and profitability efficiency. Gradual deleveraging backed by a rising equity base enhances financial flexibility and lowers structural refinancing risk, supporting strategic options over a medium-term horizon.
Bears Say
Meaningful Absolute Debt LoadDespite improvement in leverage ratios, a ~2.0B absolute debt burden keeps interest and principal servicing a material ongoing claim on cash flow. This limits flexibility for large investments or acquisitions and increases vulnerability to interest-rate or demand shocks over multiple quarters.
Volatile Revenue And Earnings MomentumInconsistent top-line performance — sharp rebound in 2025 but prior flat-to-down years and a negative recent growth metric — makes forecasting and capacity planning harder. Structural demand variability can pressure margins and returns, complicating multi-quarter strategic planning and capital allocation.
Inconsistent Cash Conversion And Earnings PeaksEarnings and cash flow are not uniformly trending upward: net income lags the prior peak and FCF showed a slight dip year-over-year, and some coverage metrics are missing. This irregularity reduces confidence in sustained free cash generation and complicates reliable debt servicing and shareholder return planning.
Rici Healthcare Holdings Ltd. News
1526 FAQ
What was Rici Healthcare Holdings Ltd.’s price range in the past 12 months?
Rici Healthcare Holdings Ltd. lowest stock price was HK$0.56 and its highest was HK$1.24 in the past 12 months.
What is Rici Healthcare Holdings Ltd.’s market cap?
Rici Healthcare Holdings Ltd.’s market cap is HK$1.64B.
When is Rici Healthcare Holdings Ltd.’s upcoming earnings report date?
Rici Healthcare Holdings Ltd.’s upcoming earnings report date is Sep 01, 2026 which is in 23 days.
How were Rici Healthcare Holdings Ltd.’s earnings last quarter?
Rici Healthcare Holdings Ltd. released its earnings results on Mar 26, 2026. The company reported HK$0.173 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.173.
Is Rici Healthcare Holdings Ltd. overvalued?
According to Wall Street analysts Rici Healthcare Holdings Ltd.’s price is currently Overvalued.
Does Rici Healthcare Holdings Ltd. pay dividends?
Rici Healthcare Holdings Ltd. pays a Notavailable dividend of HK$0.02 which represents an annual dividend yield of 1.94%. See more information on Rici Healthcare Holdings Ltd. dividends here
What is Rici Healthcare Holdings Ltd.’s EPS estimate?
Rici Healthcare Holdings Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Rici Healthcare Holdings Ltd. have?
Rici Healthcare Holdings Ltd. has 1,590,324,000 shares outstanding.
What happened to Rici Healthcare Holdings Ltd.’s price movement after its last earnings report?
Rici Healthcare Holdings Ltd. reported an EPS of HK$0.173 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 2.497%.
Which hedge fund is a major shareholder of Rici Healthcare Holdings Ltd.?
Currently, no hedge funds are holding shares in HK:1526
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Rici Healthcare Holdings Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-22.31%
12-Months-Change
Fundamentals
Return on Equity
1.94%
Trailing 12-Months
Asset Growth
5.09%
Trailing 12-Months
Company Description
Rici Healthcare Holdings Ltd.
Rici Healthcare Holdings Limited operates as an investment holding company, managing a variety of healthcare establishments across the People's Republic of China. Its operations encompass general and specialized hospitals, clinics, and medical examination centers. By the close of 2021, specifically December 31st, the company's network included 68 medical examination centers. Beyond these core activities, Rici Healthcare also offers health advisory services, nursing care, diagnostic testing, and leasing arrangements. The firm was established in 2000 and has its principal corporate office located in Shanghai, China.
Technical Analysis
Honliv Healthcare Management Group Co Ltd
―
EuroEyes International Eye Clinic Limited
―
Chaoju Eye Care Holdings Ltd.
―
C-MER Eye Care Holdings Limited
―
Town Health International Medical Group Ltd.
―